CAPRICOR THERAPEUTICS, INC. — Form D

CAPRICOR THERAPEUTICS, INC. of BEVERLY HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-19. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Earl CollierDirectorBEVERLY HILLS, CA
George DunbarDirectorAnn Arbor, MI
Joshua KazamDirectorNew York, NY
Frank LitvackDirectorMENLO PARK, CA
Louis ManzoDirectorBEVERLY HILLS, CA
Linda MarbanDirectorBEVERLY HILLS, CA
David MusketDirectorBEVERLY HILLS, CA
Deborah AscheimExecutive OfficerBEVERLY HILLS, CA
Anthony BergmannExecutive OfficerBEVERLY HILLS, CA
Leland GershellExecutive OfficerBEVERLY HILLS, CA
Karen KrasneyExecutive OfficerBEVERLY HILLS, CA
Linda MarbanExecutive OfficerBEVERLY HILLS, CA
Rachel SmithExecutive OfficerBEVERLY HILLS, CA
Andrew HamerExecutive OfficerOakville, A6
Hsiao D LieuExecutive OfficerSouth San Francisco, CA
David M TanenDirectorNew York, NY
David M TanenExecutive OfficerNew York, NY
Arie S BelldegrunDirectorNew York, NY
Daron EvansExecutive OfficerSouth Orange, NJ
Frank M LitvackDirectorPalo Alto, CA
Louis GrasmickDirectorBeverly Hills, CA
Gregory SchaferDirectorBeverly Hills, CA
Earl Collier, Jr.DirectorBeverly Hills, CA
Gregory W SchaferDirectorBerkeley, CA
Paul A MieyalDirectorLouisville, CO

Other filings by this issuer (7)

FiledFormOfferingSold
2016-03-29D$14K$14K
2015-02-19D$7.1M$7.1M
2015-02-03D$10.0M$10.0M
2014-02-24D$33K$33K
2013-12-05D$26.3M$26.3M
2011-06-27D$2.5M$2.5M
2009-07-15D$3.0M$2.3M

More